References
- Schiffman PL, Belch JM. Pulmonary function at diagnosis of amyotrophic lateral sclerosis: rate of deterioration. Chest 1993; 103: 508–513.
- Fallat RJ, Jewitt B, Bass M, Kamm B, Norris FH. Spirometry in amyotrophic lateral sclerosis. Arch Neurol 1979; 36: 74–80.
- Black LF, Hyatt RE. Maximal static respiratory pressures in generalized neuromuscular disease. Am Rev Respir Dis 1971; 103: 641–649.
- Lyall RA, Donaldson N, Polkey MI, Leigh PN, Moxham J. Respiratory muscle strength and ventilatory failure in amy- otrophic lateral sclerosis. Brain 2001; 124: 2000–2013.
- Stambler N, Charatan M, Cedarbaum JM, and the ALS CNTF Study Group. Prognostic indicators of survival in ALS. Neurology 1998; 50: 66–72.
- Kleopa K, Sherman M, Neal B, Romano G, Heiman-Patter- son T. BiPAP improves survival and rate of pulmonary func- tion decline in patients with amyotrophic lateral sclerosis. J Neurol Sci 1999; 164: 82–88.
- Polkey MI, Lyall RA, Green M, Leigh PN, Moxham J. Expira- tory muscle function in amyotrophic lateral sclerosis. Am J Respir Crit Care Med 1998; 158: 734–741.
- Bach JR. Amyotrophic lateral sclerosis: predictors for prolon- gation of life by non-invasive respiratory aids. Arch Phys Med Rehab 1995; 76: 828–832.
- Jackson CE, Rosenfeld J, Moore DH et al. A preliminary eval- uation of a prospective study of pulmonary function studies and symptoms of hypoventilation in ALS/MND patients. J Neurol Sci 2001; 191: 75–78.